SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-10-003760
Filing Date
2010-10-22
Accepted
2010-10-22 16:41:00
Documents
3
Period of Report
2010-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K peregrine_8k-102110.htm 8-K 66854
2 PRESS RELEASE peregrine_8k-ex9901.htm EX-99.1 7743
3 logo.jpg GRAPHIC 6574
  Complete submission text file 0001019687-10-003760.txt   85686
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 101137674
SIC: 2835 In Vitro & In Vivo Diagnostic Substances